| Systemic inflammatory mediators are effective biomarkers for predicting adverse outcomes in Clostridioides difficile infection MG Dieterle, R Putler, DA Perry, A Menon, L Abernathy-Close, ... MBio 11 (3), 10.1128/mbio. 00180-20, 2020 | 14 | 2020 |
| Anti-toxin antibody is not associated with recurrent Clostridium difficile infection J Gilbert, J Leslie, R Putler, S Weiner, A Standke, A Penkevich, M Keidan, ... Anaerobe 67, 102299, 2021 | 6 | 2021 |
| Systemic inflammatory mediators are effective biomarkers for predicting adverse outcomes in Clostridioides difficile infection. mBio 11: e00180-20 MG Dieterle, R Putler, DA Perry, A Menon, L Abernathy-Close, ... | 5 | 2020 |
| Changes in the association between diagnostic testing method, PCR ribotype, and clinical outcomes from clostridioides difficile infection: one institution's experience A Menon, DA Perry, J Motyka, S Weiner, A Standke, A Penkevich Clin Infect Dis, ciaa1395, 2020 | 4 | 2020 |
| Changes in the association between diagnostic testing method, polymerase chain reaction Ribotype, and clinical outcomes from Clostridioides difficile infection: one institution … A Menon, DA Perry, J Motyka, S Weiner, A Standke, A Penkevich, ... Clinical Infectious Diseases 73 (9), e2883-e2889, 2021 | 3 | 2021 |
| Oral cholestyramine prevents enrichment of diverse daptomycin-resistance mutations in intestinal Enterococcus faecium VJ Morley, DG Sim, A Penkevich, RJ Woods, AF Read bioRxiv, 2022.05. 25.493495, 2022 | 1 | 2022 |
| An orally administered drug prevents selection for antibiotic-resistant bacteria in the gut during daptomycin therapy VJ Morley, DG Sim, A Penkevich, RJ Woods, AF Read Evolution, Medicine, and Public Health 10 (1), 439-446, 2022 | | 2022 |
| Public Health Oversight of Interfacility Transfers During a Candida auris Outbreak-Orange County, California, 2019 J Motyka, A Penkevich, V Young, K Rao INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 41, S77-S78, 2020 | | 2020 |
| Recurrent Clostridioides difficile infection can be predicted using inflammatory mediator and toxin activity levels J Motyka, A Penkevich, V Young, K Rao Infection Control & Hospital Epidemiology 41 (S1), s77-s78, 2020 | | 2020 |
| 76. Validation of Systemic Inflammatory Mediators as Biomarkers for Severity and Adverse Outcomes in Clostridium difficile Infection MG Dieterle, RKB Putler, DA Perry, A Menon, L Abernathy-Close, ... Open Forum Infectious Diseases 6 (Supplement_2), S1-S2, 2019 | | 2019 |
| 2236. Stool-Derived Inflammatory Mediators Serve as Biomarkers of Severity in Clostridium difficile Infection J Motyka, A Penkevich, DA Perry, S Weiner, A Standke, M Keidan, ... Open Forum Infectious Diseases 6 (Supplement_2), S764-S765, 2019 | | 2019 |
| 2355. The Association Between Diagnostic Testing Method and Clostridium difficile Infection Severity A Menon, DA Perry, J Motyka, S Weiner, A Standke, A Penkevich, ... Open Forum Infectious Diseases 6 (Supplement_2), S811-S811, 2019 | | 2019 |
